Study title: Results of a post-marketing surveillance study Allergo J. No. 16, 193-198 Age of patients: 5 -71 Years.; Post-marketing study 1998-2001 (year)
Type of medicine: Allergen extracts | |||||
Therapeutic area: Immune System Diseases | |||||
Brands: Please see report, Please see report | |||||
MAH holders: Please see report, Please see report, Please see report | |||||
Assessment: | |||||
Active substance: Dermatophagoides farinae;Dermatophagoides pteronyssinus | |||||
ATC code: V01AA03 | |||||
Document link: | |||||
Document date: | |||||
Study number: | |||||
EudraCT number: | |||||
Scope of study: CLINICAL | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |